Delivery barriers are important because they can significantly affect the success of cancer therapies. Inadequate delivery of drugs to the tumor site can result in suboptimal treatment outcomes, increased side effects, and the development of drug resistance. Overcoming these barriers can enhance the therapeutic index of anti-cancer agents, leading to better patient outcomes.
